NCT06720610View on ClinicalTrials.gov

Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

April 25, 2025

Study Completion Date

June 27, 2025

Conditions
Erosive Esophagitis
Interventions
DRUG

Vonoprazan 20 mg

Vonoprazan PO, 20mg, once a day, 14 days.

DRUG

Esomeprazole

Esomeprazole PO, 40mg, once a day, 14 days

Trial Locations (5)

10430

Cipto Mangunkusumo Hospital, Jakarta Pusat

10620

Hermina Kemayoran Hospital, Jakarta Pusat

13320

Hermina Jatinegara Hospital, East Jakarta

16436

Hermina Depok Hospital, Depok

17141

Hermina Bekasi Hospital, Bekasi

All Listed Sponsors
lead

Indonesia University

OTHER